Jointly develop

SARS-Cov-2 Antigen Test Kit (LFIA)

Founded in 2017, Jiangsu Medomics Medical Technology Co., Ltd, as an international high-tech enterprise, focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.

At the very beginning of COVID-19 on early 2020, Medomics developed IgM/IgG antibody detecting kit with the team of Zhong Nanshan. And Medomics published the first research paper on international journal together with State Key Laboratory of Respiratory Disease. The detecting kit was validated by CDC, Harvard Medical School and Columbia University Irving Medical Center etc. Until May 2020, the kit has been exported to dozens of countries and areas, making great help against SARS-Cov-2.

In 2021, Medomics’s series product of SARS-Cov-2 detection have been developed according to ISO 13485 Quality system and European CE Certification.

Weihai Dishang Medical Technology Co. Ltd,  a subsidiary of Dishang Group, specialized in professional medical device manufacturer.

Dishang have professional R&D team, comprehensive testing laboratory,  and a 100,000-level purification workshop covering 12,000M2, with over 1200 skilled workers, operating more than 1000 sets of professional production equipment,  to produce key PPE items such as medical protective coveralls, isolation gowns and face masks. The PPE products produced obtained EU, CE Authentication, and US FDA,  exporting over 30 countries and regions across the world.

About Dishang Group

Founded in 1993, Dishang Group is one of China’s largest manufacturers and apparel export enterprises. With a turnover in excess of $1.8bn, the manufacturing base spans China, Cambodia, Myanmar and Bangladesh, to provide truly global solutions. Through our offices across Asia, Europe and America Dishang Group has built long-term partnerships with over 500 domestic and overseas apparel companies, manu-facturing 100 million garments annually.